poisar

Stocks · News reference

Mediobanca Research Maintains Neutral Rating on SOL S.p.A. Following Wentimed Acquisition

Fiscal.ai

Mediobanca Research has reaffirmed its 'neutral' recommendation for SOL S.p.A. in light of the company's recent acquisition of the Polish home care provider Wentimed.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading